 that they've become hard to get, which is a problem for patients who take the drugs for type 2 diabetes. NPR Pharmaceuticals correspondent Sydney Lupkin reports. Jim Cox had heard about people with diabetes who were unable to get their Ozempic because the drug was being used off-label for weight loss. He just didn't think it would affect him. Cox, who has type 2 diabetes, had been taking a drug called Trulicity. That's a GLP-1 drug and in the same class as Ozempic.